2018 Annual Meeting

Ohio-ACC 28th Annual Meeting & 7th Annual Richard Lewis Memorial Lecture
October 27, 2018  |  Hilton Columbus at Easton, Columbus, OH

Meeting Brochure  |  Syllabus/Disclosures  |  Posters

Special thanks to Dr. Robert Mosteller for helping with the photography.

Photos

Agenda

Saturday, October 27

7:00-7:55 a.m.
Registration, Exhibits, Posters, and Continental Breakfast

7:55-8:00 a.m.
Welcoming Remarks
Sanjay Gandhi, MD, MBA, FACC

8:00-9:00 a.m.
7th Annual Richard P. Lewis Memorial Lecture
Coronary Microvascular Dysfunction among Women: Is It a pre HFpEF Syndrome?

Carl J. Pepine, MD, MACC
handout

9:00-9:45 a.m.
Issues from the ACC: What Is Impacting CV Providers in 2018
Richard A. Chazal, MD, MACC
handout

9:45-10:30 a.m.
Break, Exhibits, Poster Competition

10:30-11:15 a.m.
Pharmacology Rapid Fire
Pulmonary Hypertension Med Update, Kevin T. Kissling, PharmD, BCPS | handout
PCSK9 Inhibitor Insights, Kelly M. Bartsch, PharmD, BCPS, CLS | handout
Moderator: Robert Barcelona, PharmD, BCPS

11:15 a.m.-12:00 noon
Considering DAPT in Difficult Cases
John McB. Hodgson, MD, FACC
handout

12:00-12:45 p.m.
Lunch Break, Exhibits, Posters
Networking Round Tables: Look for a table that interests you!

12:45-1:15 p.m.
Fellow in Training Oral Competition
Blinded Late Gadolinium Enhancement Quantification of Age Matched Adolescent and Young Adult Becker and Duchenne Muscular Dystrophy Cardiomyopathy – Pace Johnston, MD, Nationwide Children’s Hospital
Left Ventricular Outflow Tract Obstruction Leads to Decreased Myocardial Strain in Right Ventricles: Comparison of Coarctation of the Aorta, Aortic Stenosis, Hypoplastic Left Heart Syndrome and Normal Patients – Carmen Kiper, MD, Nationwide Children’s Hospital

1:15-2:00 p.m.
Septal Defects: Imaging and New PFO Data
Multimodality Imaging of Septal Defects, Kan N. Hor, MD | handout
PFO: To Close, or Not To Close, That Is the Question, K. Dean Boudoulas, MD, FACC

2:00-2:15 p.m.
Announcement of Poster Winners and Oral Competition Winners

 

Posters

Poster Submissions

Poster Competition Winners

Fellow in Training Oral Presentation

First place – Pace Johnston, MD, Nationwide Children’s Hospital

Second place – Carmen Kiper, MD, Nationwide Children’s Hospital

Fellow in Training Clinical Research Posters 1st/2nd year

First place – Haris Riaz, MD, Cleveland Clinic

Second place – Sunil Vasireddi, MD, MetroHealth

Fellow in Training Clinical Research Posters 3rd year & Advanced Fellowship

First place – Tara Cosgrove, MD, Nationwide Children’s Hospital

Second place – Teresa Ratajczak, MD, Wright State University

Fellow in Training Case Report Poster Winners

1st year – Christopher Tanayan, MD, Summa

2nd year (group A) – Jason Cole, MD, Nationwide Children’s Hospital

2nd year (group B) – Dan Washko, MD, University of Cincinnati

3rd year/advanced fellowship – Iliana Hurtado, MD, Summa

CV Team Members (RN, NP, CNS, PA, PharmD) Case Report Poster Winner

First place – Kelly Bartsch, PharmD, The Ohio State University

Resident Case Report Poster Winner

First place – Johnny Chahine, MD, Cleveland Clinic

CME/CNE

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Cardiology Foundation and Michigan Chapter of the American College of Cardiology. The American College of Cardiology Foundation is accredited by the ACCME to provide continuing medical education for physicians.

The ACCF designates this live educational activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurses

American College of Cardiology Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

The ACCF designates this live educational activity for a maximum of 4.5 continuing nursing education contact hours (1.5 pharmacotherapeutic nursing contact hours).  Each attendee should only claim credits commensurate with the extent of their participation in the activity.

While offering credits noted above, the course is not intended to provide extensive training or certification in this field.

ATTENTION Nurses who are in need of Category A credit, please visit: http://www.netce.com/3271/Catalog_OH14.pdf. Take a look at the Ohio Nurse Practice Act module on pages 3-11 and then scroll to page 91.

Statement of Need
The cardiac care team is increasingly asked to develop systems of care, the methods for which are not necessarily part of the traditional medical training, and to perform better, faster, more efficiently and at a lower cost.  Identified learning needs for 2018 Ohio CV practitioners include updates in health care legislation, coronary microvascular dysfunction among women, pharmacology updates, dual antiplatelet therapy, and septal defects.

Overall Goal
The overall goal of this activity is to increase learner competence by discovering strategies to anticipate research-driven changes in practice, to enhance professional growth, and to demonstrate efficacy in patient care practice as new clinical approaches and technologies change. The Ohio Chapter-ACC Annual Meeting will include education that provides needs-based learning covering a thorough overview of health care legislation and regulation, coronary microvascular dysfunction among women, pharmacology updates, dual antiplatelet therapy, and septal defects.

Learner Objectives

  • Identify tools, resources, and regulations that impact the practice environment.
  • Review the similarities in the clinical phenotypes of CMD patients and HFpEF patients.
  • Analyze the clinical implications of utilizing the newer pharmacological agents in the patient with cardiovascular disease.
  • Recognize cases when dual antiplatelet therapy is appropriate.
  • Identify various imaging modalities to risk stratify for septal defects and indications for PFO closure.

Target Audience
Adult Cardiologists, Pediatric Cardiologists, Cardiothoracic Surgeons, Cardiology Fellows-in-Training, Nurses, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, Pharmacists

Disclosure Policy
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC), the American College of Cardiology Foundation (ACCF) must ensure balance, independence, objectivity and scientific rigor in all of their directly provided or jointly provided/co-provided educational activities. Planners, presenters, and other contributors, in a position to control the content are required to disclose to the audience all relevant financial relationships he/she and/or his/her spouse or domestic partner may have, occurring within the past 12 months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the contributor should disclose that the product is not labeled for the use under discussion or that the product is still investigational.

ACCF is committed to providing its learners with high-quality activities and materials that promote improvements and quality in health care and not a specific proprietary business or commercial interest. The intent of this disclosure is not to prevent participation in educational activities by persons with a financial or other relationship, but rather to provide learners with information on which they can make their own determination whether financial interests or relationships may influence the education activity.

ACCF assesses conflicts of interest (COI) with its faculty, planners, managers, staff and other individuals who are in a position to control the content of CME/CNE activities. All relevant potential conflicts of interest that are identified are thoroughly vetted through a process that includes course directors and appropriate peer review by education committee chairs/members, for fair balance, scientific objectivity and validity, and patient care and safety recommendations.

Exhibitors

Appreciation is expressed to the following companies for providing an educational grant:
Actelion Pharmaceuticals US
AstraZeneca
Chiesi

Appreciation is expressed to the following companies for exhibiting at this conference:

GOLD SPONSOR – ZOLL LifeVest

SILVER SPONSORS – Amgen, AstraZeneca, OhioHealth

Abbott
Aegerion Pharmaceuticals
Akcea Therapeutics
Amarin Pharma, Inc.
Boehringer Ingelheim
Boston Scientific (2)
Bristol-Myers Squibb
Chiesi
Cincinnati Children’s Hospital Medical Center
CryoLife, Inc.
Gilead Sciences
Itamar Medical
Janssen
Kowa Pharmaceuticals America
Lantheus Medical Imaging
Medicure Pharma Inc.
Medtronic
Medtronic Structural Heart
Mercy Health
Nova Biomedical
Novartis
Phosphorus Diagnostics
Portola Pharmaceuticals
Regeneron
Sanofi US

 

Upcoming Meetings